CLOV
Get informed when a big investor buys or sells
+ FollowOvervalued by 181.3% based on the discounted cash flow analysis.
| Market cap | $2.15 Billion |
|---|---|
| Enterprise Value | $1.95 Billion |
| Dividend Yield | $0.10 (-) |
| Earnings per Share | $-0.17 |
| Beta | 2.49 |
| Outstanding Shares | 524,186,885 |
| P/E Ratio | -102.47 |
|---|---|
| PEG | 28.1 |
| Price to Sales | 1.03 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.79 |
| Enterprise Value to EBIT | -106.3 |
| Enterprise Value to Net Income | -107 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.3286▼ 25.00% |
|---|---|
| Total Calls | 10,304,600▲ 138.15% |
| Total Puts | 3,386,400▲ 35.25% |
Holdings and activity of institutional investors.
| Ownership % | 29.36%▲ 4.71% |
|---|---|
| Total Invested | $1.25B▲ 457.09% |
| Investors Holding | 240▲ 21.00% |
No data
Clover Health is a healthcare technology company with a deeply rooted mission of improving every life. Clover uses its proprietary technology platform to collect, structure, and analyze health and behavioral data to improve medical outco...